Seeking Alpha
 

United Therapeutics Corporation (UTHR)

- NASDAQ
  • Ray Dirks | Send Message 19 May

    Pluristem Chosen For Accelerated Marketing Approval In Europe $PSTI, $UTHR http://seekingalpha.com/p/2e2te
    Reply
      • Marty Chilberg | Send Message 6 May

        United Therapeutics: Solid Rare Disease Biotechnology Play For Long Haul $UTHR http://seekingalpha.com/p/2d6ri
        Reply
          • StockStatus | Send Message 28 Apr
            Reply
              • TradeIt Mike | Send Message 27 Apr

                COVER $UTHR 180.95
                Reply (1)
                • stocktrader | Send Message 27 Apr
                  : 4 pts that great mike.
                  • Fred Piard | Send Message 13 Apr

                    $UTHR up 44% since I bought it in my Market Neutral Portfolio (december)
                    Reply
                      • TradeIt Mike | Send Message 10 Apr

                        SHORT $UTHR 185.04
                        Reply
                          • Fred Piard | Send Message 8 Apr

                            $UTHR up 38% since I bought it in December.
                            Reply
                              • TradeIt Mike | Send Message 26 Mar

                                COVER $UTHR 168.15
                                Reply
                                  • Fred Piard | Send Message 16 Mar

                                    $UTHR finally up 8% today, unrlz profit 36%
                                    Reply
                                      • Fred Piard | Send Message 16 Mar

                                        $UTHR best holding in my Market Neutral Portfolio (and newsletter). +6.5% today, and more than 33% unrlz profit since late december.
                                        Reply
                                          Visit Seeking Alpha's
                                          UTHR vs. ETF Alternatives
                                          Company Description
                                          United Therapeutics Corp is a biotechnology company. The Company is engaged in thedevelopment and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening conditions.